Quotes AstraZeneca PLC Berne S.E.

Stocks

000982352

GB0009895292

Pharmaceuticals

End-of-day quote Berne S.E. 04/09/2026			5-day change	1st Jan Change
135.15 ^CHF	+2.81%		+2.20%	-6.70%

02:20am	AstraZeneca?s ETCAMAH (camizestrant) in combination with a cyclin-dependent kinase 4/6 inhibitor (abemaciclib, palbociclib or ribociclib) has been approved in the US	CI
11:26pm	AstraZeneca Wins FDA Accelerated Approval for Breast Cancer Drug Etcamah	MT

Stock exchange

Berne S.E. 000982352 135.15 CHF +2.81% 6.08K CHF

Markets		Price	Change	Volumes
NYSE	AZN	162.70USD	-1.26%	500M $
London S.E.	AZN	12,006.00GBX	-1.15%	13.54B p
NYSE	AZN	162.70USD	-1.26%	500M $
Nasdaq Stockholm	AZN	1,555.50SEK	-0.96%	847M kr
CBOE	AZN	12,010.00GBX	-1.01%	5.25B p
CBOE	AZNs	1,555.00SEK	-0.99%	319M kr
CBOE	AZN	162.67USD	-1.24%	25.46M $
CBOE	AZN	1,555.50SEK	-0.96%	6.09M kr
Tradegate	ZEG	140.05EUR	-1.13%	474K €
Boerse Muenchen	ZEG	139.80EUR	-1.20%	138K €
Deutsche Boerse AG	ZEG	140.25EUR	-1.13%	68.86K €
Börse Stuttgart	ZEG	139.65EUR	-1.31%	38.68K €
Berne S.E.	000982352	135.15CHF	+2.81%	6.08K CHF
Mexican S.E.	AZN1 N	2,777.00MXN	+2.19%	24.99K $
Buenos Aires S.E.	AZN	64,550.00ARS	-1.49%	180M $
Buenos Aires S.E.	AZND	42.10USD	-1.84%	6.78K $
Sao Paulo	A1ZN34	139.42BRL	-2.07%	356K R$

Quotes 5-day view: AstraZeneca PLC

End-of-day quote Berne S.E.

	27/08/2026	28/08/2026	31/08/2026	02/09/2026	04/09/2026
Last	CHF 131.25	CHF 132.24	CHF 132.71	CHF 131.45	CHF 135.15
Volume	70	1	41	24	45
Change	-	+0.75%	+0.36%	-0.95%	+2.81%
Opening	CHF 131.25	CHF 132.24	CHF 131.65	CHF 131.45	CHF 135.15
High	CHF 131.25	CHF 132.24	CHF 132.71	CHF 131.45	CHF 135.15
Low	CHF 131.25	CHF 132.24	CHF 131.65	CHF 131.45	CHF 135.15

Performance

1 day	+2.81%
1 week	+2.20%
Current month	+1.84%
1 month	+4.29%
3 months	-4.96%
6 months	-13.17%
Current year	-6.70%
1 year	+4.54%
3 years	+11.93%
5 years	+42.26%
10 years	+108.56%

Volumes

markets

Daily volume

Avg. Volume 20 sessions

Avg. Volume 20 sessions CHF

11,622.64

Avg. Volume 20 sessions USD

14,344.66

Record volume 1

2,494,139

Record volume 2

1,500,000

Record volume 3

1,444,460

Capital turnover ratio

Float rotation

Basic data

Market Cap (CHF)

251,786,138,707

Market Cap (USD)

251,786,138,707

Net sales (USD)

58,739,000,000

Number of employees

96,100

Sales / Employee (USD)

611,228

Free-Float

96.63 %

Free-Float capitalization (CHF)

300,510,597,344

Free-Float capitalization (USD)

243,296,384,715

Average Daily Capital Traded

Indicators

Moving average 5 days

132.56

Moving average 20 days

131.51

Moving average 50 days

138.6

Moving average 100 days

143.93

Price spread / (MMA5)

-1.91%

Price spread / (MMA20)

-2.69%

Price spread / (MMA50)

+2.55%

Price spread / (MMA100)

+6.50%

RSI 9 days

55.72

RSI 14 days

51.27

Sector Comparison:

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ASTRAZENECA PLC	+2.81%	+2.20%	+4.54%	+11.93%	252B
ELI LILLY AND COMPANY	-0.88%	-2.15%	+54.71%	+106.31%	1,024B
JOHNSON & JOHNSON	-1.15%	+2.68%	+53.97%	+71.50%	663B
ABBVIE INC.	-1.44%	+0.38%	+20.40%	+73.05%	453B
ROCHE HOLDING AG	+0.14%	-0.47%	+29.49%	+38.56%	352B
NOVARTIS AG	-1.33%	+4.72%	+24.69%	+45.55%	304B
ASTRAZENECA PLC	-1.15%	+0.30%	-1.49%	+12.31%	252B
AMGEN INC.	-1.55%	+1.11%	+56.10%	+70.32%	236B
NOVO NORDISK A/S	-0.88%	+1.15%	-17.09%	-54.39%	206B
GILEAD SCIENCES, INC.	-0.15%	+3.65%	+33.90%	+96.99%	187B
Average	-0.61%	+1.10%	+25.92%	+47.21%	393.02B
Weighted average by Cap.	-0.85%	+0.50%	+34.57%	+62.74%